(R,R)-Tramadol

(R,R)-Tramadol

SCHEMBL6543502

COc1cccc([C@@]2(O)CCCCC2CN(C)C)c1.Cl

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of (R,R)-Tramadol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 11/20 0.98
SLC6A2 P23975 13/20 0.98
SLC6A4 P31645 13/20 0.98
OPRD1 P41143 6/20 0.98
OPRK1 P41145 4/20 0.98
SLC22A1 O15245 3/20 0.98
MEN1 O00255 2/20 0.98
KMT2A Q03164 2/20 0.98
CHRM2 P08172 1/20 0.98
CHRM1 P11229 1/20 0.98

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(R,R)-Tramadol SCHEMBL29625842 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL429520 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL405854 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL41748 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL7141021 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL1377516 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL405853 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL7137387 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
Tramadol SCHEMBL6052999 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1
Tramadol SCHEMBL405855 1.00 SLC6A2 (0.98) SLC6A2SLC6A4OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077923-B1 AN IMPROVED SYNTHESIS AND PURIFICATION OF (R*,R*)-2- (DIMETHYLAMINO) METHYL]-1-( 3-METHOXYPHENYL) CYCLOHEXANOL HYDROCHLORIDE MALLINCKRODT INC (US) 2004-01-02 EP disclosed
EP-1077923-B1 AN IMPROVED SYNTHESIS AND PURIFICATION OF (R*,R*)-2- (DIMETHYLAMINO) METHYL]-1-( 3-METHOXYPHENYL) CYCLOHEXANOL HYDROCHLORIDE MALLINCKRODT INC (US) 2004-01-02 EP disclosed
US-6399829-B1 SALT FORMATION USING HYDROGEN CHLORIDE IN PRESENCE OT TOLUENE; CRYSTALLIZATION IN NITRILE SOLVENT MALLINCKRODT INC. 2002-06-04 US disclosed
US-6399829-B1 SALT FORMATION USING HYDROGEN CHLORIDE IN PRESENCE OT TOLUENE; CRYSTALLIZATION IN NITRILE SOLVENT MALLINCKRODT INC. 2002-06-04 US disclosed
EP-1077923-A1 AN IMPROVED SYNTHESIS AND PURIFICATION OF (R*,R*)-2- (DIMETHYLAMINO) METHYL]-1-( 3-METHOXYPHENYL) CYCLOHEXANOL HYDROCHLORIDE Mallinckrodt Inc. (US) 2001-02-28 EP disclosed
WO-1999061405-A1 AN IMPROVED SYNTHESIS AND PURIFICATION OF (R*,R*)-2-[ (DIMETHYLAMINO) METHYL]-1-( 3-METHOXYPHENYL) CYCLOHEXANOL HYDROCHLORIDE MALLINCKRODT INC. (US) 1999-12-02 WO disclosed